Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with INKT: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
INKT
MiNK Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
INKT
MiNK Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No disclosed counterparties: INKT.
Only INKT
0
None
Role chip = supplier or customer
Source: SEC EDGAR
AMGN
Amgen Inc
Change
461.49
· pre 450.62
· delayed
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
INKT
MiNK Therapeutics, Inc.
Change
10.01
· pre 10.01
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$51.3M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 6 '26
delayed
AMGN
Amgen Inc
vs
INKT
MiNK Therapeutics, Inc.
461.49
pre 450.62
delayed
Price
10.01
pre 10.01
delayed
$249.0B
Mkt cap
$51.3M
Q3 FY26
$10.4B
Revenue
—
FY25
$36.8B
Revenue
—
Change
Change
AMGN
461.49
vs
INKT
10.01
Pre-market
Nov 6 '26
delayed